Cargando…
Serous fluids and hematolymphoid disorders
Diagnosing hematolymphoid neoplasm by evaluating fine-needle aspiration (FNA) cytology sample is controversial and requires experience and clinical skills. This concept becomes more challenging when evaluating hematolymphoid neoplasm in body fluid. Differentiating between low-grade lymphoma and reac...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063582/ https://www.ncbi.nlm.nih.gov/pubmed/35510123 http://dx.doi.org/10.25259/CMAS_02_12_2021 |
_version_ | 1784699196324970496 |
---|---|
author | Gabali, Ali |
author_facet | Gabali, Ali |
author_sort | Gabali, Ali |
collection | PubMed |
description | Diagnosing hematolymphoid neoplasm by evaluating fine-needle aspiration (FNA) cytology sample is controversial and requires experience and clinical skills. This concept becomes more challenging when evaluating hematolymphoid neoplasm in body fluid. Differentiating between low-grade lymphoma and reactive lymphocytes is often difficult by morphology alone as reactive lymphoid cells may acquire activation morphology from being exposed to different cytokines within the body fluid. However, in most cases there are specific features that may aid in differentiating small reactive from non-reactive lymphocytes including the round shape of the nucleus, the absence of visible nucleoli and the presence of fine clumped chromatin. In large cell lymphoma and leukemia cells involvement of body fluid this concept becomes less challenging. Large cell lymphoma and leukemia cells tend to have large size nuclei, less mature chromatin, and visible nucleoli with and without cytoplasmic vacuoles. However, to reach accurate diagnosis and subclassification, the utilizing of flow cytometry, to confirm monoclonality, and other ancillary studies such immunocytochemistry, cytogenetics and molecular studies is needed. This review article will be incorporated finally as one of the chapters in CMAS (CytoJournal Monograph/Atlas Series) #2. It is modified slightly from the chapter by the initial authors in the first edition of Diagnostic Cytopathology of Serous Fluids. |
format | Online Article Text |
id | pubmed-9063582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-90635822022-05-03 Serous fluids and hematolymphoid disorders Gabali, Ali Cytojournal CytoJournal Monograph Related Review Series Diagnosing hematolymphoid neoplasm by evaluating fine-needle aspiration (FNA) cytology sample is controversial and requires experience and clinical skills. This concept becomes more challenging when evaluating hematolymphoid neoplasm in body fluid. Differentiating between low-grade lymphoma and reactive lymphocytes is often difficult by morphology alone as reactive lymphoid cells may acquire activation morphology from being exposed to different cytokines within the body fluid. However, in most cases there are specific features that may aid in differentiating small reactive from non-reactive lymphocytes including the round shape of the nucleus, the absence of visible nucleoli and the presence of fine clumped chromatin. In large cell lymphoma and leukemia cells involvement of body fluid this concept becomes less challenging. Large cell lymphoma and leukemia cells tend to have large size nuclei, less mature chromatin, and visible nucleoli with and without cytoplasmic vacuoles. However, to reach accurate diagnosis and subclassification, the utilizing of flow cytometry, to confirm monoclonality, and other ancillary studies such immunocytochemistry, cytogenetics and molecular studies is needed. This review article will be incorporated finally as one of the chapters in CMAS (CytoJournal Monograph/Atlas Series) #2. It is modified slightly from the chapter by the initial authors in the first edition of Diagnostic Cytopathology of Serous Fluids. Scientific Scholar 2022-03-19 /pmc/articles/PMC9063582/ /pubmed/35510123 http://dx.doi.org/10.25259/CMAS_02_12_2021 Text en © 2022 Cytopathology Foundation Inc, Published by Scientific Scholar https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | CytoJournal Monograph Related Review Series Gabali, Ali Serous fluids and hematolymphoid disorders |
title | Serous fluids and hematolymphoid disorders |
title_full | Serous fluids and hematolymphoid disorders |
title_fullStr | Serous fluids and hematolymphoid disorders |
title_full_unstemmed | Serous fluids and hematolymphoid disorders |
title_short | Serous fluids and hematolymphoid disorders |
title_sort | serous fluids and hematolymphoid disorders |
topic | CytoJournal Monograph Related Review Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063582/ https://www.ncbi.nlm.nih.gov/pubmed/35510123 http://dx.doi.org/10.25259/CMAS_02_12_2021 |
work_keys_str_mv | AT gabaliali serousfluidsandhematolymphoiddisorders |